Over the last 12 months, one Cocrystal Pharma, Inc. company insiders picked up shares with their own money, about $301,000 in total, and none of them sold.
FROST PHILLIP MD ET AL (Director) made the biggest buy, worth around $70,000.
Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 3 of the last 7 full quarters. On the institutional side, 27 funds reported holding COCP at the end of Q2 2026, and more funds sold than bought.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | FROST PHILLIP MD ET AL | Director | Buy | 10,000 | $0.98 | $10K | SEC |
| Aug 5, 2026 | FROST PHILLIP MD ET AL | Director | Buy | 75,000 | $0.94 | $70K | SEC |
| Feb 25, 2026 | FROST PHILLIP MD ET AL | Director | Buy | 20,000 | $1.00 | $20K | SEC |
| Feb 9, 2026 | FROST PHILLIP MD ET AL | Director | Buy | 50,000 | $0.95 | $48K | SEC |
| Jan 2, 2026 | FROST PHILLIP MD ET AL | Director | Buy | 50,000 | $0.95 | $48K | SEC |
| Dec 31, 2025 | FROST PHILLIP MD ET AL | Director | Buy | 20,000 | $0.97 | $19K | SEC |
| Dec 29, 2025 | FROST PHILLIP MD ET AL | Director | Buy | 25,000 | $0.97 | $24K | SEC |
| Dec 29, 2025 | FROST PHILLIP MD ET AL | Director | Buy | 40,000 | $0.97 | $39K | SEC |
| Nov 28, 2025 | FROST PHILLIP MD ET AL | Director | Buy | 2,500 | $0.99 | $2K | SEC |
| Nov 28, 2025 | FROST PHILLIP MD ET AL | Director | Buy | 1,500 | $1.00 | $2K | SEC |
| Nov 25, 2025 | FROST PHILLIP MD ET AL | Director | Buy | 20,000 | $0.94 | $19K | SEC |
| Apr 6, 2023 | FROST PHILLIP MD ET AL | Director | Buy | 1,015,229 | $1.97 | $2.0M | SEC |
In the last 12 months Cocrystal Pharma, Inc. insiders made open-market purchases worth about $301,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in COCP was filed on 2026-08-06.
27 investment managers reported holding COCP in SEC Form 13F filings for Q2 2026.
No congressional trades in COCP were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).